Editor's key points † Measuring cardiac output (CO) in neonates is complex due to shunt. † CO was measured in lambs with a surgical left-to-right aorto-pulmonary shunt, using two methods. † Transpulmonary ultrasound dilution was reliable even with a left-to-right-shunt. † The technique may be useful in critically ill children and neonates.
It is plausible that CO monitoring can prevent these risks. In addition, CO monitoring could optimize cardiovascular management as CO and not low arterial pressure will be targeted to start inotropic support in these critically ill newborns.
During the period of transition, patent fetal channels influence the results of most CO measurement technologies making objective measurement even more complicated. Functional echocardiography is increasingly being used to assess CO, myocardial (dys)function, intra-and extracardiac shunts, and organ blood flow. 11 12 However, as this method is labour-intensive and expertise in echocardiography is required, it cannot be considered as an instant bedside monitoring system. Many of the other current CO measurement techniques have not been validated in patients with shunts, 13 -15 with the exception of the modified carbon dioxide Fick method. 16 Transpulmonary ultrasound dilution (TPUD) was introduced in 1995 to enable measurement of several haemodynamic parameters in patients during haemodialysis. 17 18 The technique was adapted for CO measurements and tested in vitro, 19 in animals, 20 -22 adults, 23 -25 and children, 26 27 using isotonic saline at body temperature as an indicator, that is injected in a low-volume extracorporeal arterio-venous (AV) tubing loop inserted between an indwelling arterial and central venous catheter. Recently, the method was validated in juvenile piglets and proven to be reproducible, accurate, and safe. 28 29 The aim of this study was to validate the accuracy and precision of the TPUD technology in a lamb model with an intermittently opened and closed left-to-right shunt under different haemodynamic conditions.
Methods

Transpulmonary ultrasound dilution
TPUD is based on the difference in ultrasound velocity in blood and the indicator (isotonic saline at body temperature) and uses an extracorporeal AV loop that can be connected to any indwelling arterial and central venous catheter (Fig. 1) . The AV loop is flushed with heparinized saline (1 U ml 21 ) to prevent thrombosis. A peristaltic pump provides stable blood flow during measurement. The indicator is injected into the venous limb and a venous sensor calculates the exact amount of injected indicator and the ultrasound velocity of the used saline. An arterial sensor measures the decrease in ultrasound velocity in blood by the injected saline. An ultrasound dilution curve is obtained, from which CO is calculated using the Stewart-Hamilton equation. After two to three measurements, the loop is flushed and the pump stopped. The method has been described extensively. 28 An ultrasonic transit-time flow probe positioned around the main pulmonary artery was used as a reference method for measurement of blood flow, which is considered the gold standard in an animal model. 30 
Animals
This experiment was performed in accordance with Dutch national legislation concerning guidelines for the care and use of laboratory animals, was approved by the Ethical Committee on Animal Research of the Radboud University Nijmegen (RU-DEC #2008-117), and was part of a multidisciplinary CO study 31 performed in seven random-bred lambs (3. 4.0 -6.0 kPa). A servo-controlled heating mattress and a heating radiator were used to maintain a rectal temperature between 388C and 398C. At the end of the experiment, the animals were euthanized with a lethal dose of pentobarbital (150 mg kg 21 i.v.).
Instrumentation
Immediately after induction of anaesthesia, intravascular catheters were surgically inserted. was used to prevent shunt thrombosis. Adequately sized perivascular ultrasonic transit-time flow probes (PAX series, Transonic w Systems Inc., Ithaca, NY, USA) were used to measure blood flow in the main pulmonary artery (COufp) and proximal (Q AOpre ) and distal (Q AOpost ) to the aortopulmonary shunt on the descending aorta. We chose to place the flow probe around the main pulmonary artery and not the ascending aorta as this latter (i) does not include the coronary blood and (ii) does not measure true systemic flow in the presence of a left-to-right shunt. A flow probe positioned around the main pulmonary artery (proximally to the shunt insertion) measures right ventricular output which reflects the systemic blood flow in the absence of an intracardiac shunt, irrespective of a potential left-to-right aorto-pulmonary shunt.
Before each TPUD measurement, the adequacy of signal strength of the flow probes was checked. The flow probes were checked for zero value directly post-mortem.
Experimental protocol
After a 15 min stabilization period, the study protocol was started (Fig. 2) . During the experiment, the aorto-pulmonary shunt was intermittently closed and opened fully by (un)clamping. CO was manipulated by creating haemorrhagic hypotension by gradually withdrawing blood, therefore decreasing the mean arterial pressure by 10 mm Hg over a period of 5 min. After each intervention, one session of TPUD measurements-consisting of three consecutive injections with 1.0 ml kg 21 isotonic saline-was performed.
We 33 The coefficient of variation (CV) for both measurement methods was calculated as 100×(SD per session/mean CO per session). The variance of the TPUD method and the reference method was also expressed as the coefficient of error (CE) and calculated as (SD per session/mean CO per session)/ p 3 with 3 the number of measurements in one session, as described by Cecconi and colleagues. 34 Mean bias (with 95% confidence interval) and LOA were also calculated for COtpud based first on the initial injection of saline and, respectively, the mean of the first two and all three injections in one session for the groups with a closed and an open shunt. the two methods as described by Critchley and colleagues. 35 The distance from the centre of the plot (vector) represents the mean change in CO. The angle with the horizontal (08 radial) axis represents disagreement. The less the disagreement between CO measurements, the closer the data pairs will lie along the horizontal radial axis. Good trending is defined when the data are situated within the 10% boundaries. SPSS 16.0.01 for Windows w (SPSS Inc., Chicago, IL, USA) was used for statistical analysis. The polar plot was created with SigmaPlot for Windows version 7.1 (Systat Software, Inc., San Jose, CA, USA). Table 1 shows the characteristics of the study population. The native ductus arteriosus was found to be closed in all animals.
Results
A total of 72 sessions (with each three measurements) were performed and analysed. Open shunt Closed shunt The CE for COtpud measurements with the closed shunt was 1.9% and for measurements with the open shunt 2.6%. We noticed no significant correlation between bias and shunt fraction (r 2 ¼0.03), mean arterial pressure (r 2 ¼0.03), weight (r 2 ¼0.02), and heart rate (r 2 ¼0.02).
The polar plot (Fig. 4) shows good trending in every group as most of the data points lie inside the limits of good agreement (i.e. 10%¼0.1 litre min 21 as mean CO¼1.0 litre min 21 ). Table 2 shows the mean bias and LOA between COufp and COtpud based first on the initial injection of saline and, respectively, the mean of the first two injections and all three injections for measurements with closed and open shunts. With additional injections, we noticed a slight, but not significant improvement in both the accuracy (bias) and the precision.
Discussion
Our study shows that CO can reliably be measured using the TPUD in an animal model with a left-to-right shunt. CO was measured within a large range of Qp/Qs (1.3-2.6). With an open (left-to-right) shunt, accuracy and precision decreased in comparison with measurements with a closed shunt. Although almost statistically significant, the increased bias was not of any clinical relevance as the bias percentage was still low. The altered accuracy is the result of a change in the dilution curve in the presence of a left-to-right aortopulmonary shunt (Fig. 5A and B) . The initial height of the curve is somewhat lower as a smaller amount of indicator reaches the arterial sensor during the first pass. However, the downslope is slurred, wider, and asymmetric due to the shunt circulation. The indicator that has shunted from the aorta through the shunt to the pulmonary artery appears later in the curve as it reaches the sensor in a delayed way. The primary curve-representing the dilution curve that would have been produced in the absence of shunt circulation-is calculated by the COstatus software (Fig. 5C ). The principle of the software algorithm is to define the optimal segment for extrapolation that can eliminate the influence of indicator recirculation. If the elimination is accurate, agreement between the dilution technique measurements and the flow probe measurements should be close. The overestimation of CO in the presence of a left-to-right shunt in our study is possibly due to a somewhat larger elimination of indicator recirculation performed by the algorithm from the COstatus. Comparison with other methods is hampered. Reports using lithium dilution (LidCO) excluded patients with shunts as CO measurements were not reliable. 13 14 Transpulmonary thermodilution (TPTD) is widely used and accepted to measure CO in adults and older children, but literature about the influence of shunts is scarce. 36 37 A recently published article shows that measuring CO in lambs with a left-to-right shunt is feasible.
31
Our results also showed a subtle decrease in precision in the presence of a shunt. However, this finding is not significant and to our opinion merely based on coincidence. Despite this small decrease in precision, the percentage error for measurements with open shunt was within the acceptable range of ,30% as proposed by Critchley and Critchley 33 and used by others. 34 -39 The percentage error in other paediatric, adult, and animal studies (in patients with higher ranges of CO and without shunts) with the TPTD technique varies from 9.5% to 31.4%. This study shows that the ultrasound dilution technique is one of the first technologies that can reliably measure CO in the presence of a significant left-to-right shunt. But as Cecconi and colleagues 34 stated, the 30% margin may lead to erroneous conclusions if the precision of the reference technique is not included. The CE of our reference method was 0.9%. The CE of TPUD was 2.6% for measurements with the open shunt and 1.9% for measurements with the closed shunt. This implies that TPUD is about 2.3 times less precise than our reference method. In our opinion, this is still very acceptable in clinical practice because (i) TPUD is compared with the gold standard for CO measurement with excellent precision and (ii) CE is equal to or lower than in other studies using TPTD in children, even in the presence of a shunt. 40 -42 In this study, we also compared changes in COufp and COtpud during haemorrhage because not only the absolute CO measurement, but also the capability to track changes in CO make a technique more valuable for clinical use. As shown in Figure 4 , all data pairs-except one-were situated within the 10% boundaries. This makes the TPUD a reliable device to measure small changes in CO, even in the presence of a shunt.
The TPUD technique has many benefits: it uses a non-toxic indicator at body temperature, which implies no (thermal) loss of indicator during the measurement period. There is also no loss of sampled blood, because all blood is redirected to the patient. Set-up time is 6 min; results are shown 1 min after injection. Changes in cerebral blood flow, cerebral blood volume (measured by near infrared spectroscopy), heart rate, and arterial pressure during subsequent actions required for TPUD measurements were not clinically relevant in an animal model. 29 Table 2) . Currently, the TPUD method only provides intermittent CO measurements. Continuous CO monitoring is only available in a prototype. Invasive arterial pressure measurement is not possible during the 5-6 min period of CO measurements with TPUD. TPUD is to our opinion a feasible method to use in newborns, including preterm infants. Vena cava superior flow measurements are nowadays a substitute for systemic blood flow in the neonatal intensive care. However, intensive training to optimize measurements is necessary, and even with experienced observers, there is a large interand intra-observer variability. 43 Unlike the TPTD method, TPUD uses an indicator at body temperature. Although CO measurements are feasible in the presence of a left-to-right shunt with TPTD, the results are less precise than with TPUD. 31 Especially, the necessity for a dedicated catheter makes the use of TPTD less attractive in newborn infants as this catheter cannot be used in children smaller than 3.5 kg. Our study has some limitations. First, we used only a small number of animals. Secondly, possible interatrial shunting through a patent foramen ovale (PFO) was not ruled out. This phenomenon is often seen in neonates with a (moderate to large) patent ductus arteriosus. 44 The presence of a PFO can alter the effect of a ductus arteriosus by decompressing the left atrium. The right ventricular output then might consequently be higher than the left ventricular output. Although no echocardiographic studies were done, no large PFO was expected as Q AOpre was significantly higher than
COufp with an open shunt. We conclude that measuring CO with TPUD is reliable in neonatal lambs in the presence of a significant left-to-right shunt covering a wide range of CO. This makes the TPUD technique a promising method to measure CO not only in critically ill children, but also in neonates, even during the transition from fetal to neonatal circulation.
